 |
ArchiveBig Pharma M&A On The Way For Biotech Stocks? (MRK, PFE, ALXN, DNDN, HGSI, CEPH, UTHR, BMRN, CADX, ONXX)Posted by Todd Shriber at 12:16PM on January 31st
Biotechs are frequently mentioned as takeover candidates for large pharmaceuticals firms looking to enhance their drug pipelines and Barron’s offered up a list of 13 biotech firms that could draw the interest of big pharma, news that is helping boost the…  Biotech Shares Pump Up The Volume (ONXX, MNTA, DNDN, ARNA, VVUS, JAZZ, MNKD, CYTX)Posted by Owen Vater at 11:16AM on July 26th
Recently we’ve been directing investors’ attention to volume spikes as a means of identifying the most tradable stocks in volatile equity segments. So often do biotech shares “float” in either direction on relatively sparse news that relative volume is often… FDA Disappointment, Earnings Send Biotech Shares Plummeting (ARIA, ALTUQ, GILD, AMGN, DNDN, CELG, ITMN, ONXX, SGMO, CRXX, VVUS, MRK)Posted by Jason Smith at 2:58PM on May 5th
Interune (ITMN) is off by more than -70% today after the FDA said the firm would have to run another clinical trial before the company’s Esbriet lung-disease treatment could be considered for approval. Traders were active in the stock, sending volume… Healthcare Guru Adds Selected Biotech, Pharma StakesPosted by Max Magee at 10:03AM on November 11th
For healthcare investors, Sectoral Asset Management has been a Pro to watch. According to the firm’s website, it is “an industry-leading specialist in managing global investment portfolios in the healthcare sector” and manages $4 billion in assets. Sectoral has been known… Healthy Gains for Cancer Treatment StocksPosted by Max Magee at 12:30PM on May 28th
The cancer therapy sector was up big on Thursday on deal making news and new potential for treatments. The American Society of Clinical Oncology (ASCO), which begins Friday and lasts through Tuesday, is the biggest event of the year for cancer… Bad Data a Risk for Healthcare-Focused ProPosted by Max Magee at 9:24AM on May 11th
For investors interested in healthcare stocks, investment firm Sectoral Asset Management, which specializes in the healthcare sector, has been a Pro to watch. However, the firm may have been stung by a major healthcare stock flame out last month. Looking at… |
|
Follow us on
  |
| Home | Find | Research | Track | Register | My Account | Logout | Web site design by LightMix |
| © 2007-2013 Indie research Corp. All rights reserved. |